Skip header and navigation
The BC Cancer Library

Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.

  Refine by:

Refine by:

Format

4 records – page 1 of 1.

Managing the oral effects of cancer treatment : diagnosis to survivorship

https://bccalibrary.andornot.com/en/permalink/catalog20461
Oncology Nursing Society. Pittsburgh, PA: Oncology Nursing Society , 2011.
Audience
Professional
Call Number
WY156 M266 2011
Availability
6 copies, 6 available
More Information
Corporate Author
Oncology Nursing Society
Editor
Haas, Marilyn L
McBride, Deborah L
Place of Publication
Pittsburgh, PA
Publisher
Oncology Nursing Society
Publication Date
2011
Physical Description
xvi, 294 p. : ill. ; 23 cm.
Subjects
Oral Manifestations
Neoplasms - nursing
Neoplasms - therapy
Neoplasms - complications
Antineoplastic Agents - adverse effects
Radiotherapy - adverse effects
Notes
CN Library copy is housed in the UHNBC Library.
ISBN
9781935864035
Language
English
Material Type
Book
Audience
Professional
Location
Vancouver Library
Kelowna Library
Surrey Library
Victoria Library
Abbotsford Library
CN Library
Call Number
WY156 M266 2011

Copies

c.1 BC Cancer Agency ARHCC Library Available
c.1 BC Cancer Agency CN Library Available
c.1 BC Cancer Agency KEL Library Available
c.1 BC Cancer Agency SUR Library Available
c.1 BC Cancer Agency VAN Library Available
c.1 BC Cancer Agency VIC Library Available
Show Less

Chimeric antigen receptor t-cell therapies for cancer : a practical guide

https://bccalibrary.andornot.com/en/permalink/catalog122174
Cambridge, MA: Elsevier, Inc. , 2020.
Audience
Professional
Call Number
QZ266 C538 2020
Availability
3 copies, 3 available
Contents:; Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients r…
More Information
Editor
Lee, Daniel W.
Shah, Nirali N.
Place of Publication
Cambridge, MA
Publisher
Elsevier, Inc.
Publication Date
2020
Physical Description
xiv, 229 p. : ill. ; 24 cm.
Subjects
Neoplasms - therapy
Receptors, Chimeric Antigen - therapeutic use
Receptors, Antigen, T-Cell
Immunotherapy, Adoptive - methods
Cell- and Tissue-Based Therapy
Abstract
Contents:
Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients receiving CAR therapy -- Neurotoxicities after CAR-T cell immunotherapy -- Hematologic and non-CRS toxicities -- Response assessment and post-CAR-T cell therapy management -- Relapse management and role for consolidative hematopoietic stem cell transplantation following CAR-T cell therapy -- Promising chimeric antigen receptors for non-B cell hematological malignancies, pediatric solid tumors, and carcinomas -- CAR T cell therapy for CNS malignancies -- CAR 2.0: the next generation of synthetic receptor-based cellular therapy for cancer.
ISBN
9780323661812
Language
English
Material Type
Book
Audience
Professional
Location
Vancouver Library
Abbotsford Library
Victoria Library
Call Number
QZ266 C538 2020

Copies

c.1 BC Cancer Agency VAN Library Available
c.1 BC Cancer Agency ARHCC Library Available
c.1 BC Cancer Agency VIC Library Available
Show Less

RANK ligand : a key signal in cancer-induced bone disease and hormone ablative therapy-induced bone loss

https://bccalibrary.andornot.com/en/permalink/catalog19811
Amgen Inc. Thousand Oaks, Calif.: Amgen Inc. , 2009.
Audience
Professional
Call Number
WE258 R198 2009
Availability
1 copy, 1 available
Introduction; RANK ligand in bone biology; Bone metastases; Multiple myeloma; Skeletal-related events (SREs); Hormone ablative therapy-induced bone loss
More Information
Author
Amgen Inc.
Place of Publication
Thousand Oaks, Calif.
Publisher
Amgen Inc.
Publication Date
2009
Subjects
RANK Ligand - metabolism
Osteoblasts
Osteoclasts
Antibodies, Monoclonal - therapeutic use
Bone Neoplasms - secondary
Bone Resorption
Osteoporosis - therapy
Antineoplastic Agents, Hormonal - adverse effects
Abstract
Introduction
RANK ligand in bone biology
Bone metastases
Multiple myeloma
Skeletal-related events (SREs)
Hormone ablative therapy-induced bone loss
Language
English
Material Type
Video
DVD
Audience
Professional
Location
Abbotsford Library
Call Number
WE258 R198 2009

Copies

c.1 BC Cancer Agency ARHCC Library Available
Show Less

Lapatinib in HER-2 over-expressing MBC : extending treating options

https://bccalibrary.andornot.com/en/permalink/catalog19851
Chia, Stephen. [Vancouver, BC?]: BC Cancer Agency. Multi-Media Services , 2010.
Audience
Professional
Call Number
WP870 C532l 2010
Availability
3 copies, 3 available
More Information
Author
Chia, Stephen
Place of Publication
[Vancouver, BC?]
Publisher
BC Cancer Agency. Multi-Media Services
Publication Date
2010
Subjects
Breast Neoplasms - therapy
Antibodies, Monoclonal - therapeutic use
Neoplasm Metastasis
Adjuvants, Pharmaceutic
Antineoplastic Agents
Language
English
Material Type
CD
Audience
Professional
Location
Vancouver Library AV Room
Kelowna Library
Abbotsford Library
Call Number
WP870 C532l 2010

Copies

c.1 BC Cancer Agency ARHCC Library Available
c.1 BC Cancer Agency KEL Library Available
c.1 BC Cancer Agency VAN Library AV Room Available
Show Less